Other News To Note
Thursday, December 8, 2011
Cubist Pharmaceuticals Inc., of Lexington, Mass., said 36.1 million shares of Exton, Pa.-based Adolor Corp. were initially tendered under Cubist's $415 million offer to acquire the biotech. That figure represents about 75 percent of Adolor's shares, and Cubist commenced a subsequent offering period that is scheduled to expire Dec. 9.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.